Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cost Analysis of Therapies for Severe Anemia
Sponsor: Helios Klinik Gotha/Ohrdruf
Summary
The goal of this observational study is to learn about the costs that occur when participants with severe anemia are treated with blood transfusions or with patient blood management (PBM). PBM means that the body of the participant is stimulated to produce new blood by itself rather than receiving it from a blood donor, and to reduce blood losses. The main question the study aims to answer is: Do participants treated with transfusions incur the same treatment costs than participants treated with PBM? And how much costs are this in relation to the lives saved by the therapy of severe anemia?
Official title: Cost Effectiveness Analysis of Transfusion Therapy and Patient Blood Management in Patients With Severe Anemia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
640
Start Date
2024-04-01
Completion Date
2026-05-01
Last Updated
2024-04-03
Healthy Volunteers
No
Conditions
Interventions
Patient blood management (PBM)
PBM means the medical enhancement of the participants own hematopoietic reserve to treat anemia and to reduce the ill effects of disease and bleeding on hematopoiesis and homeostasis.
Allogeneic transfusion
transfusion of donor red cells